Skip to main content

Table 2 Final EULAR/PRINTO/PReS criteria for granulomatosis with polyangiitis (GPA, Wegener’s) [8]

From: ANCA-associated vasculitis in childhood: recent advances

Criterion

Glossary

Sensitivity (%)

Specificity (%)

1-Histopathology

Granulomatous inflammation within the wall of an artery or in perivascular or extravascular area

54

99.6

2-Upper airway involvement

Chronic purulent or bloody nasal discharge or recurrent epistaxis/crusts/granulomata

Nasal septum perforation o saddle nose deformity

Chronic or recurrent sinus inflammation

83

99

3-Laryngo-tracheo-bronchial

involvement

Subglottic, tracheal or bronchial stenoses

22

99.8

4-Pulmonary involvement

Chest x-ray or CT showing the presence of nodules, cavities or fixed infiltrates

78

92

5-ANCA

ANCA positivity by immunofluorescence or by ELISA (MPO/p or PR3/c ANCA)

93

90

6-Renal involvement

Proteinuria >0.3 g/24 ore or > 30 mmol/mg of urine albumin/creatinine ratio on a spot morning sample

Haematuria or red blood cell casts: >5 red blood cells/high power field or red blood cell casts in the urinary sediment or ≥2+ on dipstick

Necrotising pauci-immune glomerulonephritis

65

69.6

Childhood-WG EULAR/PRINTO/PRES

Ankara 2008 classification

At least three of the six following criteria:

Histopathology

Upper airway involvement

Laryngo-tracheo-bronchial stenosis

Pulmonary involvement

ANCA positivity

Renal involvement

93.3

99.2

  1. ANCA, anti-neutrophil cytoplasmic antibody; WG, Wegener granulomatosis; EULAR, European League Against Rheumatism; PReS, Paediatric Rheumatology European Society; PRINTO, Paediatric Rheumatology International Trials Organisation